Ethanolic extract of Melia azedarach L. induces melanogenesis through the cAMP-PKA-CREB signaling pathway

다국어 초록 (Multilingual Abstract)

Backgrounds: Since the cause of hypopigmentary skin disorders (hair graying and vitiligo) is typically unknown, there is no known cure for these disorders. Melia azedarach L. is used in Southeast Asia across China and Japan as a traditional medicine, and it has been reported to have various pharmacological properties. However, there have been no reports to demonstrate the involvement of M. azedarach L. in pigmentation. This study was conducted to investigate the effect of ethanolic extract of M. azedarach L. (MAE) on melanogenesis and to elucidate its mechanism of action in B16F10 mouse melanoma cells and human epidermal melanocytes.
Methods: Effects of MAE on melanogenesis and its mechanism of action were investigated using several assays, including melanin content, cellular tyrosinase activity, real-time PCR analysis, Western blot analysis, and ELISAs for cyclic AMP (cAMP), protein kinase A (PKA), cAMP response element binding (CREB) protein, and mitogen-activated protein kinases (MAPKs).
Results: MAE increased the melanin content levels and cellular tyrosinase activity in B16F10 mouse melanoma cells and human epidermal melanocytes. In addition, the action mechanism of MAE-induced melanogenesis was examined in human epidermal melanocytes. It also upregulated the expressions of microphthalmia-associated transcription factor (MITF) gene and its downstream target genes, tyrosinase and tyrosinase-related protein (TRP) 1, but not TRP 2. MAE treatment increased the cAMP levels, PKA activity, and phosphorylation of CREB protein, its downstream signaling protein.
However, MAE showed no effects on MAPKs (p42/ 44 MAPK, p38 MAPK, and c-Jun-N-terminal kinase (JNK)).
Conclusion: These findings indicate that MAE induces melanogenesis by upregulating the MITF gene through the cAMP-PKA-CREB signaling pathway, and they suggest its potential in the treatment of hypopigmentary skin diseases.

참고문헌 (Reference)

• 1 Huang, H. C., "[6]-Shogaol inhibits α-MSH-induced melanogenesis through the acceleration of ERK and PI3K/Akt-mediated MITF degradation" 2014 : 842569-, 2014
• 2 Schallreuter, K. U., "Vitiligo pathogenesis: Autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?" 17 : 139-140, 2008
• 3 Ezzedine, K., "Vitiligo is not a cosmetic disease" 73 : 883-885, 2015
• 4 Rad, H. H., "Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells" 298 : 317-328, 2004
• 5 Brenner, M., "The protective role of melanin against UV damage in human skin" 84 : 539-549, 2008
• 6 Namba, T., "The Encyclopedia of Wakan-Yaku (Traditional Sino-Japanese Medicines) with Color Pictures Vol. I" Hoikusya Co. Ltd 1994
• 7 Minamitsuji, Y., "Sulfur containing tyrosine analogs can cause selective melanocytotoxicity involving tyrosinasemediated apoptosis" 4 : 130-136, 1999
• 8 Lee, J., "Rosmarinic acid induces melanogenesis through protein kinase A activation signaling" 74 : 960-968, 2007
• 9 Ezzedine, K., "Revised classification/nomenclature of vitiligo and related issues: The Vitiligo Global Issues Consensus Conference" 25 : E1-E13, 2012
• 10 Alerico, G. C., "Proliferative effect of plants used for wound healing in Rio Grande do Sul state, Brazil" 176 : 305-310, 2015
• 11 McDonough, P. H., "Premature hair graying" 89 : 161-165, 2012
• 12 Akihisa, T., "Nitric oxide production-inhibitory activity of limonoids from Azadirachta indica and Melia azedarach" 14 : e1600468-, 2017
• 13 Okada, M., "Newly Revised Illustrated Medicinal Plants of World" Hokuryukan Publishing Co. Ltd 2002
• 14 Namazi, M. R., "Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo:Can they be interconnected?" 20 : 360-363, 2007
• 15 Vishnukanta, A. C. Rana, "Melia azedarach: A phytopharmacological review" 2 : 173-179, 2008
• 16 d’Ischia, M., "Melanins and melanogenesis : from pigment cells to human health and technological applications" 28 : 520-544, 2015
• 17 Videria, I. F. S., "Mechanisms regulating melanogenesis" 88 : 76-83, 2013
• 18 Huh, S., "Mechanisms of melanogenesis inhibition by propafenone" 302 : 561-565, 2010
• 19 Eby, J. M., "Immune responses in a mouse model of vitiligo with spontaneous epidermal de-and repigmentation" 27 : 1075-1085, 2014
• 20 Kim, H. J., "Hyperpigmentation mechanism of methyl 3, 5-di-caffeoylquinate through activation of p38 and MITF induction of tyrosinase" 47 : 548-556, 2015
• 21 Lin, M., "Ginsenosides Rb1 and Rg1 stimulate melanogenesis in human epidermal melanocytes via PKA/CREB/MITF signaling" 2014 : 892073-, 2014
• 22 Fu, Y. T., "Extracts of Artocarpus communis decrease α-melanocyte stimulating hormone-induced melanogenesis through activation of ERK and JNK signaling Pathways" 2014 : 724314-, 2014
• 23 Oode, C., "Dihydroresveratrol cellobioside and xylobioside as effective melanogenesis activators" 436 : 45-49, 2016
• 24 Jian, D., "Diethylstilbestrol enhances melanogenesis via cAMP-PKA-mediating up-regulation of tyrosinase and MITF in mouse B16 melanoma cells" 76 : 1297-1304, 2011
• 25 Sheth, V. M., "Development and pilot testing of a vitiligo screening tool" 307 : 31-38, 2015
• 26 Pan, X. 1., "Cytotoxic and nitric oxide productioninhibitory activities of limonoids and other compounds from the leaves and bark of Melia azedarach" 11 : 1121-1139, 2014
• 27 Valacchi, G., "Cutaneous responses to environmental stressors" 1271 : 75-81, 2012
• 28 Khan, M. F., "Bioactivity-guided chemical analysis of Melia azedarach L. (Meliaceae), displaying antidiabetic activity" 98 : 98-103, 2014
• 29 Lucena, A. P. S., "Antioxidant activity and phenolics content of selected Brazilian wines" 23 : 30-36, 2010
• 30 Gu, W. J., "Additive effect of heat on the UVB-induced tyrosinase activation and melanogenesis via ERK/p38/MITF pathway in human epidermal melanocytes" 306 : 583-590, 2014
• 31 Dessinioti, C., "A review of genetic disorders of hypopigmentation : lessons learned from the biology of melanocytes" 18 : 741-749, 2009